GRND vs HNGE: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. GRND and HNGE share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined GRND and HNGE exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Grindr operates the world's largest social networking and dating app built for gay, bi, trans, and queer people, with a freemium model that mirrors the rest of the app economy. The core app is free, and the company earns money two ways: Direct revenue from premium subscriptions (the XTRA and Unlimited tiers) plus in-app purchases, and Indirect revenue from its advertising technology business. In Q1 2026 it reported ~$129.9 million of revenue, up 38% year over year, with app-based revenue up 33% and advertising up 68%. Average paying users reached 1.4 million, up 19%, helped by a price increase that began rolling out in the second half of 2025. Profitability is unusually strong for a dating app: Q1 2026 adjusted EBITDA was ~$58.5 million, a 45% margin, and management raised full-year 2026 guidance to at least $535 million of revenue and at least $227 million of adjusted EBITDA.

Full GRND guide

Hinge Health is a digital musculoskeletal (MSK) care platform that provides physical therapy, pain management, and surgery prevention services through a combination of software, connected sensor hardware, and human care teams. The company's core offering combines a mobile and connected-sensor app with personalized exercise therapy programs, behavioral health support, and access to physical therapists, plus care navigation for surgery decisions. Customers are primarily large employers and health plans that purchase Hinge Health benefits for their members.

Full HNGE guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• GRND drivers: A loyal, defensible user base; Two revenue engines growing together.
• HNGE drivers: Employer benefit penetration; Surgery prevention as ROI driver.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The clearest overhang is control and governance: two shareholders hold a majority of the stock, and their 2025 attempt to take Grindr private at $18 per share collapsed over financing uncertainty, which can create volatility and leaves minority holders exposed to insider decisions. For HNGE, digital health categories are competitive with various platforms targeting MSK and other condition areas.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick GRND if you believe its drivers more; HNGE if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the GRND and HNGE guides.

GRND. Figures are approximate and tied to the asOf date, so verify live numbers before acting. Management raised full-year 2026 guidance to at least $535 million of revenue and at least $227 million of adjusted EBITDA. GRND trades at a growth premium (a P/E near ~29 and price-to-sales near ~6), which reflects its high margins and growth rate rather than a typical mature-app multiple, so the figures matter most as a gauge of how much optimism is priced in.

HNGE. Hinge Health's valuation reflects the digital health growth premium, the demonstrated category leadership in MSK, and the path-to-profitability story. As a recent IPO, valuation is sensitive to broader digital health sector sentiment and to quarterly progression toward profitability.

Headline figures (approximate, July 2026): GRND shows revenue (q1 2026 quarterly) ~$129.9 million, up 38% year over year, adjusted ebitda (q1 2026) ~$58.5 million, a ~45% margin, net income (q1 2026) ~$26.8 million ($0.14 per share), average paying users ~1.4 million, up 19% year over year; HNGE shows revenue (ttm) ~$400 million (estimated, post-IPO disclosure), operating margin Approaching breakeven; varies by quarter, net income (ttm) Modest GAAP loss; non-GAAP near breakeven, eps (ttm) Near zero.

GRND and HNGE are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined GRND and HNGE exposure against your real portfolio. It is not an investment adviser.